|
|
MiT4 |
|
Vaxjo ID |
177 |
|
Vaccine Adjuvant Name |
MiT4 |
|
Adjuvant VO ID |
VO_0005285
|
|
Description |
TLR4 agonist that induces Th1 response |
|
Stage of Development |
Research |
|
Location Licensed |
US (PAI Life sciences Seattle, WA) |
|
Host Species for Testing |
Mouse |
|
Storage |
2-8C |
|
Function |
Type: TLR agonist vaccine adjuvant. Target Receptor: Toll-like receptor 4 (TLR4). Induces Th1-biased immune profile. |
| References |
(Carter, 2025): [https://vac.niaid.nih.gov/view?id=16]
|
|
